Trial intelligence / Profile preview

Effect of ursodeoxycholic acid on breast milk jaundice

IRCT2017013028154N1Phase 2Completed

Sponsor
Shiraz University of Medical Sciences
Start
Feb 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2 trial of ursodeoxycholic acid in breast milk jaundice (BMJ), sponsored by Shiraz University of Medical Sciences. Started Feb 2017; status: completed.

02

Drugs

ursodeoxycholic acid
03

Conditions

breast milk jaundice (BMJ)

Beyond the preview

Go deeper on IRCT2017013028154N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017013028154N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call